Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Angiodynamics (ANGO) Leases (2019 - 2026)

Angiodynamics' Leases history spans 8 years, with the latest figure at $5.4 million for Q1 2026.

  • For Q1 2026, Leases rose 25.86% year-over-year to $5.4 million; the TTM value through Feb 2026 reached $5.4 million, up 25.86%, while the annual FY2025 figure was $3.8 million, 33.67% down from the prior year.
  • Leases reached $5.4 million in Q1 2026 per ANGO's latest filing, down from $5.7 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $7.6 million in Q1 2022 to a low of $3.4 million in Q3 2025.
  • Average Leases over 5 years is $5.2 million, with a median of $5.1 million recorded in 2023.
  • Peak YoY movement for Leases: crashed 35.8% in 2025, then increased 25.86% in 2026.
  • A 5-year view of Leases shows it stood at $5.7 million in 2022, then decreased by 28.6% to $4.1 million in 2023, then grew by 17.03% to $4.8 million in 2024, then grew by 19.18% to $5.7 million in 2025, then dropped by 5.52% to $5.4 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Leases are $5.4 million (Q1 2026), $5.7 million (Q4 2025), and $3.4 million (Q3 2025).